Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso

[1]  D. Cirillo,et al.  Applying a Standardized Approach to Strengthen Performances of GeneXpert Networks programme: lessons learned from Burkina Faso, 2019 , 2020, ERJ Open Research.

[2]  C. Gilpin,et al.  Tuberculosis Supranational Reference Laboratories: A Global Approach. , 2019, Clinics in chest medicine.

[3]  D. Falzon,et al.  Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam , 2019, PLoS medicine.

[4]  P. Nahid,et al.  Advances in clinical trial design for development of new TB treatments: A call for innovation , 2019, PLoS medicine.

[5]  D. Cirillo,et al.  ASAP-GxNet project in Burkina Faso: fulfil country capacity gaps to ensure efficient utilisation of GeneXpert instruments in tuberculosis care and cascade , 2019, ERJ Open Research.

[6]  N. Arinaminpathy,et al.  Supplement to: Constructing care cascades for active tuberculosis: a strategy for program monitoring and identifying gaps in quality of care Corresponding author: , 2019 .

[7]  Alimuddin Zumla,et al.  Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants , 2018, BMC Medicine.

[8]  Zhi Zhen Qin,et al.  Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016 , 2018, Gates open research.

[9]  M. Pai,et al.  Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress? , 2017, European Respiratory Journal.

[10]  Madhukar Pai,et al.  Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? , 2016, European Respiratory Journal.

[11]  Nimalan Arinaminpathy,et al.  Understanding the incremental value of novel diagnostic tests for tuberculosis , 2015, Nature.

[12]  N. Ford,et al.  Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. , 2015, Journal of clinical epidemiology.

[13]  C. Dye,et al.  The impact of new tuberculosis diagnostics on transmission: why context matters. , 2012, Bulletin of the World Health Organization.

[14]  I. Ruprah,et al.  Does technical assistance matter? An impact evaluation approach to estimate its value added , 2009 .

[15]  E. Rakotonirina,et al.  [Factors associated with tuberculosis treatment non-compliance in Antananarivo city, Madagascar]. , 2009, Sante publique.

[16]  R. Forsman,et al.  The impact of the laboratory on disease management. , 2006, Disease management : DM.

[17]  J. Henzen.  Publisher's note , 1979, Brain Research.

[18]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[19]  Adjima Combary,et al.  Applying a Standardised Approach to Strengthen Performances of GeneXpert Networks (ASAP-GxNet) program: lessons learned from Burkina Faso, 2019 , 2020 .

[20]  F. Klaus.  Report 2020 , 2020 .

[21]  L. Gabbasova,et al.  Global tuberculosis report (2014) , 2014 .